379.31
price down icon2.51%   -9.78
pre-market  Pre-market:  379.31  
loading
Elevance Health Inc stock is traded at $379.31, with a volume of 1.13M. It is down -2.51% in the last 24 hours and down -4.00% over the past month. Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$389.09
Open:
$387.69
24h Volume:
1.13M
Relative Volume:
0.65
Market Cap:
$82.26B
Revenue:
$201.11B
Net Income/Loss:
$4.95B
P/E Ratio:
16.86
EPS:
22.4991
Net Cash Flow:
$6.29B
1W Performance:
+1.73%
1M Performance:
-4.00%
6M Performance:
+2.22%
1Y Performance:
+27.89%
1-Day Range:
Value
$376.60
$389.24
1-Week Range:
Value
$365.38
$396.00
52-Week Range:
Value
$273.71
$436.24

Elevance Health Inc Stock (ELV) Company Profile

Name
Name
Elevance Health Inc
Name
Phone
(800) 331-1476
Name
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Name
Employee
97,100
Name
Twitter
Name
Next Earnings Date
2026-07-15
Name
Latest SEC Filings
Name
ELV's Discussions on Twitter

Compare ELV vs UNH, CVS, CI, HUM

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ELV icon
ELV
Elevance Health Inc
379.31 82.26B 201.11B 4.95B 6.29B 22.50
UNH icon
UNH
Unitedhealth Group Inc
423.56 384.65B 450.13B 14.91B 23.62B 15.55
CVS icon
CVS
Cvs Health Corp
106.89 136.38B 407.94B 2.90B 7.39B 2.2771
CI icon
CI
Cigna Group
286.29 75.73B 278.13B 6.74B 7.66B 23.60
HUM icon
HUM
Humana Inc
394.50 47.36B 137.20B 1.15B 1.27B 9.3439

Elevance Health Inc Stock (ELV) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-08-26 Initiated Evercore ISI In-line
Feb-03-26 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-08-26 Upgrade Wolfe Research Peer Perform → Outperform
Dec-19-25 Downgrade Deutsche Bank Buy → Hold
Oct-14-25 Initiated Goldman Neutral
Jul-21-25 Downgrade Argus Buy → Hold
Jul-18-25 Downgrade Leerink Partners Outperform → Market Perform
Apr-15-25 Downgrade Robert W. Baird Outperform → Neutral
Mar-17-25 Upgrade Argus Hold → Buy
Jan-22-25 Downgrade Stephens Overweight → Equal-Weight
Oct-18-24 Downgrade Argus Buy → Hold
Jul-18-24 Downgrade BofA Securities Buy → Neutral
Jun-24-24 Initiated Morgan Stanley Overweight
May-30-24 Initiated Robert W. Baird Outperform
Mar-06-24 Initiated Barclays Overweight
Jul-12-23 Downgrade Wolfe Research Outperform → Peer Perform
Apr-27-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Mar-28-23 Upgrade RBC Capital Mkts Sector Perform → Outperform
Sep-09-22 Upgrade BofA Securities Neutral → Buy
Aug-22-22 Upgrade SVB Leerink Mkt Perform → Outperform
View All

Elevance Health Inc Stock (ELV) Latest News

pulisher
Jul 23, 2026

AE1H Bond Profile — Key Metrics - TradingView

Jul 23, 2026
pulisher
Jul 22, 2026

AE1P Bond Profile — Key Metrics - TradingView

Jul 22, 2026
pulisher
Jul 22, 2026

Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run - Yahoo Finance

Jul 22, 2026
pulisher
Jul 21, 2026

Elevance Health stock trades steadily as earnings and Medicare growth shape investor focus - Ad-hoc-news.de

Jul 21, 2026
pulisher
Jul 21, 2026

Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Jul 21, 2026
pulisher
Jul 21, 2026

Elevance Health, Inc. (ELV) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks

Jul 21, 2026
pulisher
Jul 21, 2026

The Hidden Engine Behind Elevance Health Stock's Next Climb - Trefis

Jul 21, 2026
pulisher
Jul 21, 2026

Elevance Health stock trades steadily as earnings and Medicaid growth shape investor focus - Ad-hoc-news.de

Jul 21, 2026
pulisher
Jul 20, 2026

Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch

Jul 20, 2026
pulisher
Jul 20, 2026

Elevance Health Inc Stock Price Live, Charts & News - The Economic Times

Jul 20, 2026
pulisher
Jul 20, 2026

Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now? - The Motley Fool

Jul 20, 2026
pulisher
Jul 20, 2026

AE1D Bond Profile — Key Metrics - TradingView

Jul 20, 2026
pulisher
Jul 20, 2026

AE1J Bond Profile — Key Metrics - TradingView

Jul 20, 2026
pulisher
Jul 19, 2026

Elevance Health President Acquires 1.9% More Stock - Moomoo

Jul 19, 2026
pulisher
Jul 18, 2026

Elevance Health, Inc. (ELV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks

Jul 18, 2026
pulisher
Jul 17, 2026

Elevance Health director Peru buys $366,050 in company stock - Investing.com UK

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Preparing to Exit Several Medicaid States - RamaOnHealthcare

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 - Bitget

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health Price Target Raised to $395.00/Share From $364.00 by Leerink Partners - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Insider Buying: Ramiro Peru Acquires Shares of Elevance Health I - GuruFocus

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health CEO Snaps Up Stock After Post-Earnings Slide - Barron's

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health director Peru buys $366,050 in company stock By Investing.com - Investing.com South Africa

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health, Inc. (ELV) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health, Inc. $ELV Shares Acquired by Bank of New York Mellon Corp - InsuranceNewsNet

Jul 17, 2026
pulisher
Jul 17, 2026

What's a Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets? - Trefis

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook? - The Motley Fool

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366 - Stock Titan

Jul 17, 2026
pulisher
Jul 17, 2026

Form 4 Elevance Health Inc For: 17 July By Investing.com - Investing.com South Africa

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares - Stock Titan

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health CEO Gail Boudreaux buys $1.0m in company stock By Investing.com - Investing.com Australia

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health CEO Gail Boudreaux buys $1.0m in company stock - Investing.com Nigeria

Jul 17, 2026
pulisher
Jul 17, 2026

Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform Rating - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform Rating - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Morgan Stanley Maintains Elevance Health(ELV.US) With Hold Rating, Maintains Target Price $404 - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says - Moomoo

Jul 17, 2026
pulisher
Jul 17, 2026

Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE) - The Globe and Mail

Jul 17, 2026
pulisher
Jul 17, 2026

These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings - Sahm

Jul 17, 2026
pulisher
Jul 17, 2026

Elevance Health Chairman Increases Stock Holdings - Intellectia AI

Jul 17, 2026
pulisher
Jul 16, 2026

Elevance Health stock holds near earnings context - ad-hoc-news.de

Jul 16, 2026
pulisher
Jul 16, 2026

Lobbying Update: $60,000 of ELEVANCE HEALTH INC. lobbying was just disclosed - Quiver Quantitative

Jul 16, 2026
pulisher
Jul 16, 2026

Elevance Health earnings call: growth levers amid strain - The Globe and Mail

Jul 16, 2026
pulisher
Jul 16, 2026

Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jul 16, 2026
pulisher
Jul 16, 2026

AE1N Bond Profile — Key Metrics - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

RBC Lowers Price Target on Elevance Health to $424 From $439, Keeps Sector Perform Rating - Moomoo

Jul 16, 2026
pulisher
Jul 16, 2026

Goldman Sachs Adjusts Price Target on Elevance Health to $395 From $370, Maintains Neutral Rating - Moomoo

Jul 16, 2026
pulisher
Jul 16, 2026

Guggenheim Adjusts Price Target on Elevance Health to $455 From $399, Maintains Buy Rating - Moomoo

Jul 16, 2026
pulisher
Jul 16, 2026

Wells Fargo Adjusts Price Target on Elevance Health to $473 From $492, Maintains Overweight Rating - Moomoo

Jul 16, 2026
pulisher
Jul 16, 2026

Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says - marketscreener.com

Jul 16, 2026
pulisher
Jul 16, 2026

Elevance Health Stock Tumbles Despite Revenue Beat and Raised Full-Year Guidance - TIKR.com

Jul 16, 2026
pulisher
Jul 16, 2026

Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive - Yahoo Finance

Jul 16, 2026
pulisher
Jul 16, 2026

The Medicaid Problem Weighing On Elevance Health Stock - Trefis

Jul 16, 2026

Elevance Health Inc Stock (ELV) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
CI CI
$286.29
price up icon 0.51%
HUM HUM
$394.50
price down icon 0.78%
CCI CCI
$74.57
price down icon 3.78%
CNC CNC
$63.74
price down icon 3.26%
CVS CVS
$106.89
price down icon 1.10%
Cap:     |  Volume (24h):